Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 92,523 | 73,993 | 13,991 | 13,481 | 27,771 |
| Gross Profit | 92,523 | 73,993 | 13,991 | 13,481 | 27,771 |
| Operating Expenses | 259,829 | 210,438 | 138,405 | 123,464 | 93,877 |
| Operating Income | -167,306 | -136,445 | -124,414 | -109,983 | -66,106 |
| Other Income | 1,297 | 11,525 | 5,516 | 1,561 | 9,116 |
| Pre-tax Income | -166,009 | -124,920 | -118,898 | -108,422 | -56,990 |
| Income Tax | 21 | -62 | -27 | 32 | 24 |
| Net Income Continuous | -166,030 | -124,858 | -118,871 | -108,454 | -57,014 |
| Net Income | $-166,030 | $-124,858 | $-118,871 | $-108,454 | $-57,014 |
| EPS Basic Total Ops | -2.92 | -2.38 | -2.59 | -2.68 | -1.52 |
| EPS Basic Continuous Ops | -2.92 | -2.38 | -2.59 | -2.68 | -1.52 |
| EPS Diluted Total Ops | -2.92 | -2.38 | -2.59 | -2.68 | -1.52 |
| EPS Diluted Continuous Ops | -2.92 | -2.38 | -2.59 | -2.68 | -1.52 |
| EPS Diluted Before Non-Recurring Items | -2.92 | -2.38 | -2.59 | -2.68 | -1.52 |
| EBITDA(a) | $-163,461 | $-132,504 | $-120,667 | $-107,158 | $-64,430 |